Mathieu Bourdenx

Affiliations: 
Albert Einstein College of Medicine, New York, New York, United States 
Area:
Neuroscience, Neurodegeneration, Protein aggregation, Proteostasis, Aging, Lysosomes, Prion
Google:
"Mathieu Bourdenx"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Geier EG, Bourdenx M, Storm NJ, et al. (2018) Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia. Acta Neuropathologica
Scrivo A, Bourdenx M, Pampliega O, et al. (2018) Selective autophagy as a potential therapeutic target for neurodegenerative disorders. The Lancet. Neurology. 17: 802-815
Chansel-Debordeaux L, Bourdenx M, Dutheil N, et al. (2018) Systemic gene delivery by single-dose intracardiac administration of scAAV2/9 and scAAV2/rh10 variants in newborn rats. Human Gene Therapy Methods
Bastide MF, Glangetas C, Doudnikoff E, et al. (2017) Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia. Scientific Reports. 7: 2348
Cavaliere F, Cerf L, Dehay B, et al. (2017) In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains. Neurobiology of Disease. 103: 101-112
Bourdenx M, Dovero S, Thiolat ML, et al. (2017) Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the model. Scientific Reports. 7: 45831
Bourdenx M, Dehay B. (2017) [Autophagy and brain: the case of neurodegenerative diseases]. Medecine Sciences : M/S. 33: 268-274
Soria FN, Pampliega O, Bourdenx M, et al. (2017) Exosomes, an Unmasked Culprit in Neurodegenerative Diseases. Frontiers in Neuroscience. 11: 26
Bourdenx M, Dehay B. (2016) What lysosomes actually tell us about Parkinson's disease? Ageing Research Reviews. 32: 140-149
Dehay B, Decressac M, Bourdenx M, et al. (2016) Targeting α-synuclein: Therapeutic options. Movement Disorders : Official Journal of the Movement Disorder Society
See more...